interactions with tirzepatide and levothyroxine: guide to managing both medications safely patientsafety #glp1 #tirzepatide #obesitymedicine #elililly

McLean BA, Wong CK, Kaur KD, Seeley RJ, Drucker DJ

Diabetics May Not Realize They Have Stomach Paralysis Stomach paralysis does not always cause symptoms, especially in the early stages

European Union: Novo Nordisk's core semaglutide patent (EP 1 934 235) expires in December 2023, the same as the U.S

Share any observations with your diabetes care team, who may adjust your overall treatment regimen if problematic patterns emerge

Jason Fowler is widely praised for his highly knowledgeable, thorough, and reassuring care

Included were adults with type 2 diabetes taking semaglutide, other GLP-1 drugs (dulaglutide, exenatide) or non-GLP-1 receptor medications (empagliflozin, sitagliptin, glipizide) from December 2017 to December 2023